company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5271043.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5271043.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19640.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,98369.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-365646.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5518680.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5518680.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7582.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7582.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7582.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,49048.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,49048.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,49048.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:04:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5477214.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3149710.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3149710.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18046.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,94957.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,164487.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-889581.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3761801.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3761801.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4903.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4903.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4903.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,54777800.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-702716.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,54075084.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,54075084.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,50308380.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 17:01:12+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,206000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9527975.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9527975.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18381.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,86093.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,506123.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,841888.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8075490.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8075490.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3534.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3534.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3534.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15458.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,15458.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,15458.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8063566.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,229056.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4981115.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4981115.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5453.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,86899.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,431368.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1765909.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6223304.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6223304.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,19050.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,19050.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,19050.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6204254.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,244055.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6567989.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6567989.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5260.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,87714.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,480080.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,948903.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5046032.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5046032.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-702716.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,23511962.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,702716.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,23511962.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,23511962.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18465930.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,241403.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 16:06:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10344910.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 16:06:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10344910.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 16:06:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5929.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 16:06:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,88536.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 16:06:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,990584.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 16:06:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-678129.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 16:06:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9937990.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 16:06:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9937990.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 16:06:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18803.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 16:06:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18803.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 16:06:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18803.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 16:06:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9956793.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 16:06:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,238750.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16829254.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16829254.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18076.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,218489.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,830701.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1936794.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13825194.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13825194.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-83437.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-83437.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-83437.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8201.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8201.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13900430.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,362104.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17021010.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17021010.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14534.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,217603.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,832283.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-939266.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16895856.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16895856.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21061.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21061.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21061.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-33646.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2200.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-31446.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-31446.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16948363.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:35:38+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,358125.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16377696.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16377696.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15231.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,185234.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,654891.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1580536.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13941804.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13941804.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15637.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15637.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15637.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1260.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3000000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,46477.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3045217.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3045217.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10912224.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,366084.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11355519.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11355519.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15165.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,171551.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,663779.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5436874.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5068150.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5068150.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-35000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10554552.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,79095.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10598647.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10598647.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5530497.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,420200.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16894775.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16894775.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32070.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,192612.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,834047.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2649856.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13186190.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13186190.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15302.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15302.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15302.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-94.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-62000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,37980448.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,223228.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,38141582.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,38141582.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,24940090.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,434591.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17416000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17416000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18158.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,184000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1435000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13550000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29329000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29329000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-46000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-46000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-46000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,139257000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,549000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,139380000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,139380000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,110005000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 07:31:13+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,430000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24970000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24970000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21842.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,187000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1426000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,15359000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7976000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7976000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1266000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1266000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6710000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,439000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27570000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27570000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,34000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1719000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3596000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22207000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22207000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-18879000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,20000000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,695000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1816000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1816000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20391000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,357000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8720000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8720000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,570000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-405000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1153000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3334000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13042000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13042000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-642000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-642000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-642000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,19322000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,121000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-10000000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,82991000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-139044000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2993000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-49603000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-49603000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-63287000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,374000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29406000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29406000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,15000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2365000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2835000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24176000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24176000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,94219000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,239000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,94020000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,94020000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,69844000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 07:31:20+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,322000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24805000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24805000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,14000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2675000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4423000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17678000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17678000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,44822000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,44822000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27135000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,303000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32312000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32312000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,15000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2478000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,411000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29398000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29398000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1668000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,29208000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,31000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,27571000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,27571000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1827000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,291000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12591000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12591000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,457000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-44000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2805000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9527000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,672000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,672000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-454000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-454000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-454000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2719000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,275000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,44111000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,13625000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-169112000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-299000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-114119000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-114119000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-113901000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1495000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,114000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1791000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1734000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3565000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3565000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-109000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-109000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-109000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2844000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,8010000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,95000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5261000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5261000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8717000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:08:56+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,488000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20425000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20425000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,107000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2802000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-484000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18000000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18000000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-484000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2000000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2484000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2484000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-22899000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,46516000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,23617000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,23617000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3133000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1379000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19637000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19637000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,147000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1495000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1173000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19168000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19168000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-198000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1500000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1698000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1698000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10000000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10000000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10000000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10866000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-491000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18780000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18780000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,83000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-21868000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1430000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-41995000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-41995000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2000000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,161410000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,159352000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,159352000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1156000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1163000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1163000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,116194000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,950000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29432000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29432000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4805000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-14581000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12211000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-51419000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-51419000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-504000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-166383000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-166887000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-166887000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-48605000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,112893000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,124716000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7606000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,181398000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,181398000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-36908000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:20:15+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,4480000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55780000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55780000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3689000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11323000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13562000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-54330000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-54330000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-423000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2000000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2423000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2423000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,115759000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-398000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,115361000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,115361000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,58608000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27860000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27860000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4393000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,19312000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-59267000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1539000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-64961000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-64961000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-516000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-516000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-516000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-486000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-329000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-815000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-815000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-66292000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,8779000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-835000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-835000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-247000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,1000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-246000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-246000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-906000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-906000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-906000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1987000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26532000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26532000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4474000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2339000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12924000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-37321000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-37321000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1209000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1221000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1221000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1301000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,75000000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-72000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,73635000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,73635000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,35093000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:20:15+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,4486000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36180000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36180000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3947000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12279000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5722000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25676000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25676000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-882000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-882000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-882000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26558000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4276000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-213382000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-213382000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4263000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,11624000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,170823000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-150000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26822000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26822000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26822000.0
"Melinta Therapeutics, Inc.",MLNT,,0001461993,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4305000.0
